Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VG101 for Vulvar and Vaginal Atrophy
NCT00453089Phase 2Unknown
- Sponsor
- Bionovo
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VG101 in Vulvovaginal atrophy (VVA), sponsored by Bionovo. Status: unknown.
02
Drugs
VG101
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT00453089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453089.